NYSE
HQH
Last Price
US $21.73
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Abrdn Healthcare Investors carries no debt; cash flow comfortably covers obligations.
Financial stability - Healthy cash flow growth.
Abrdn Healthcare Investors's free cash flow has increased 0.00% from $0.00 last year to $0.00, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Abrdn Healthcare Investors's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Abrdn Healthcare Investors has insufficient data to evaluate this check.
Financial stability - Net debt/EBITDA.
Abrdn Healthcare Investors has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Abrdn Healthcare Investors earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
Abrdn Healthcare Investors's profit margin has decreased (-33.03%) in the last year from 1.72K% to 1.15K%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Abrdn Healthcare Investors's short-term assets of $2.61M exceed its short-term liabilities of $1.21M
Increasing performance - ROA.
Abrdn Healthcare Investors's return on assets of 23.58% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Abrdn Healthcare Investors's return on equity of 24.03%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Abrdn Healthcare Investors's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Abrdn Healthcare Investors had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Abrdn Healthcare Investors has positive free cash flow, indicating the company generates cash after capital expenditures
Decreasing performance - FCF yield.
Abrdn Healthcare Investors has a free cash flow yield of 0.00%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Decreasing performance - Healthy earnings growth.
Abrdn Healthcare Investors's yearly earnings has decreased -46.68% since last year from $184.95M to $98.61M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Abrdn Healthcare Investors's yearly revenue has increased 826.84% since last year from $10.77M to $99.81M, signaling increasing performance
Increasing performance - ROIC.
ROIC 15.82% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Abrdn Healthcare Investors's 3-year revenue CAGR of 129.38% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Abrdn Healthcare Investors had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Abrdn Healthcare Investors had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Abrdn Healthcare Investors has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Abrdn Healthcare Investors has an earnings yield of 21.83%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Abrdn Healthcare Investors is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Abrdn Healthcare Investors has an EV/EBITDA ratio of 7.13x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Abrdn Healthcare Investors has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Abrdn Healthcare Investors has a price-to-book ratio of 1.08x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
Abrdn Healthcare Investors has a price-to-sales ratio of 55.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
24.03%
Return on equity
ROIC: 15.82%
Valuation History
4.5X
Price to Earnings
EV/EBITDA: 7.1X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $21.73
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.